Type II Secretory Phospholipase A2 and Prognosis in Patients with Stable Coronary Heart Disease: Mendelian Randomization Study

Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease

(2010) Ziad Mallat et al.   CIRCULATION

Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke Prevention

(2010) Meng Lee et al.   STROKE

Future Role for Selective Phospholipase A2 Inhibitors in the Prevention of Atherosclerotic Cardiovascular Disease

(2009) Robert S. Rosenson   CARDIOVASCULAR DRUGS AND THERAPY

Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease

(2009) W. Koenig et al.   EUROPEAN HEART JOURNAL

Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease

(2009) Paul Elliott   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Secretory phospholipase A2: A multifaceted family of proatherogenic enzymes

(2009) Robert S. Rosenson et al.   Current Cardiology Reports

Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence

(2008) Wolfgang Koenig et al.   CARDIOVASCULAR DRUGS AND THERAPY

Role of secretory phospholipases in atherogenesis

(2008) Ann-Cathrine Jönsson-Rylander et al.   Current Atherosclerosis Reports

Elevated C-Reactive Protein in Atherosclerosis — Chicken or Egg?

(2008) Heribert Schunkert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease

(2008) Jeppe Zacho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream

(2008) Eric J Brunner et al.   PLOS MEDICINE

Mendelian Randomisation and Causal Inference in Observational Epidemiology

(2008) Nuala A Sheehan et al.   PLOS MEDICINE